Johnson & Johnson Innovative Medicine Uk

Johnson & Johnson Innovative Medicine Uk company information, Employees & Contact Information

At Johnson & Johnson Innovative Medicine, we are leading where medicine is going. Our diverse portfolio focuses on areas of medicine where we can make the biggest difference: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina. We employ over 400 dedicated individuals across the UK who work tirelessly to address the serious health problems of today and develop the potential medicines of tomorrow, championing patients every step of the way. Our Guidelines: The content available on this channel is for information purposes only. The content is not intended to provide professional medical advice, diagnosis, or treatment. Always seek medical advice from your GP or a qualified healthcare professional for questions regarding a medical condition. Johnson & Johnson is not responsible for third-party materials appearing on this channel, including but not limited to linked third-party videos, linked third-party sites and third-party advertisements. Johnson & Johnson does not control or endorse the third-party content and makes no representations regarding its accuracy.  Johnson & Johnson values the insight and opinions of people who wish to take part in the LinkedIn community, however, we operate in a highly regulated environment. Please help us by not talking directly about specific products or named medicines. We will not moderate any comments before they appear on the page. However, it may be necessary to remove comments if they mention medicines directly or could be offensive to people. If your post relates to an adverse event or product quality complaint related to a specific medication, the company may contact you to obtain further information. CP-445297 | Apr 2024

Company Details

Employees
76
Address
50-100 Holmers Farm Way, High Wycombe,england Hp12 4eg,united Kingdom
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
High Wycombe, England
Looking for a particular Johnson & Johnson Innovative Medicine Uk employee's phone or email?

Johnson & Johnson Innovative Medicine Uk Questions

News

5 ways J&J is innovating in medicines and therapies - Johnson & Johnson

5 ways J&J is innovating in medicines and therapies Johnson & Johnson

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community - Johnson & Johnson

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community Johnson & Johnson

Policies and reports - Johnson & Johnson

Policies and reports Johnson & Johnson

What you need to know about Johnson & Johnson’s 2025 third-quarter earnings - Johnson & Johnson

What you need to know about Johnson & Johnson’s 2025 third-quarter earnings Johnson & Johnson

Leading where medicine is going - Johnson & Johnson

Leading where medicine is going Johnson & Johnson

How J&J is advancing the fight against Alzheimer’s disease - Johnson & Johnson

How J&J is advancing the fight against Alzheimer’s disease Johnson & Johnson

Our culture of inclusion - Johnson & Johnson

Our culture of inclusion Johnson & Johnson

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated - Johnson & Johnson

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated Johnson & Johnson

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer Johnson & Johnson

Data science & digital health - Johnson & Johnson

Data science & digital health Johnson & Johnson

Discovery, product development & supply - Johnson & Johnson

Discovery, product development & supply Johnson & Johnson

Clinical trials - Johnson & Johnson

Clinical trials Johnson & Johnson

Johnson & Johnson ’s approach to pricing - Johnson & Johnson

Johnson & Johnson ’s approach to pricing Johnson & Johnson

Our Credo and our purpose - Johnson & Johnson

Our Credo and our purpose Johnson & Johnson

Cardiopulmonary - Johnson & Johnson

Cardiopulmonary Johnson & Johnson

Neuroscience - Johnson & Johnson

Neuroscience Johnson & Johnson

Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis - Johnson & Johnson

Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis Johnson & Johnson

J&J CareCommunity - Johnson & Johnson

J&J CareCommunity Johnson & Johnson

What you need to know about Johnson & Johnson's 2025 second-quarter earnings - Johnson & Johnson

What you need to know about Johnson & Johnson's 2025 second-quarter earnings Johnson & Johnson

5 things we now know about eczema (a.k.a., atopic dermatitis) - Johnson & Johnson

5 things we now know about eczema (a.k.a., atopic dermatitis) Johnson & Johnson

How Johnson & Johnson researchers are working to help patients at risk of developing multiple myeloma - Johnson & Johnson

How Johnson & Johnson researchers are working to help patients at risk of developing multiple myeloma Johnson & Johnson

What you need to know about Johnson & Johnson’s 2025 first-quarter earnings - Johnson & Johnson

What you need to know about Johnson & Johnson’s 2025 first-quarter earnings Johnson & Johnson

Oncology - Johnson & Johnson

Oncology Johnson & Johnson

New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis - Johnson & Johnson

New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis Johnson & Johnson

Pre-approval access - Johnson & Johnson

Pre-approval access Johnson & Johnson

Patient resources - Johnson & Johnson

Patient resources Johnson & Johnson

Myasthenia gravis - Johnson & Johnson

Myasthenia gravis Johnson & Johnson

Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference - Business Wire

Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference Business Wire

Partnerships | J&J Innovative Medicine - Johnson & Johnson

Partnerships | J&J Innovative Medicine Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list - Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list Johnson & Johnson

Johnson & Johnson’s investigational seltorexant shows numerically higher response in patients with depression with insomnia symptoms, with fewer side effects compared to quetiapine XR - Johnson & Johnson

Johnson & Johnson’s investigational seltorexant shows numerically higher response in patients with depression with insomnia symptoms, with fewer side effects compared to quetiapine XR Johnson & Johnson

Precision medicine - Johnson & Johnson

Precision medicine Johnson & Johnson

Johnson & Johnson: Changing health for humanity | J&J Switzerland - Johnson & Johnson

Johnson & Johnson: Changing health for humanity | J&J Switzerland Johnson & Johnson

"The surgical devices I design for Johnson & Johnson can help speed healing and save lives" - Johnson & Johnson

"The surgical devices I design for Johnson & Johnson can help speed healing and save lives" Johnson & Johnson

Immunology | J&J Innovative Medicine EMEA - Johnson & Johnson

Immunology | J&J Innovative Medicine EMEA Johnson & Johnson

Using your own cells to fight cancer - Johnson & Johnson

Using your own cells to fight cancer Johnson & Johnson

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer - Johnson & Johnson

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer Johnson & Johnson

What you need to know about Johnson & Johnson's 2024 fourth-quarter and full-year earnings report - Johnson & Johnson

What you need to know about Johnson & Johnson's 2024 fourth-quarter and full-year earnings report Johnson & Johnson

Empowering Healthcare Entrepreneurs with the Start-up Initiative - Johnson & Johnson

Empowering Healthcare Entrepreneurs with the Start-up Initiative Johnson & Johnson

Inspiring the Next Generation in STEM - Johnson & Johnson

Inspiring the Next Generation in STEM Johnson & Johnson

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company - Johnson & Johnson

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company Johnson & Johnson

Myeloid malignancies - Johnson & Johnson

Myeloid malignancies Johnson & Johnson

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025 - Business Wire

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025 Business Wire

50 years of meeting healthcare needs in Singapore - Johnson & Johnson

50 years of meeting healthcare needs in Singapore Johnson & Johnson

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Investing News Network

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference Investing News Network

Nov 11 Fireside Chat: Johnson & Johnson at UBS Global Healthcare Conference — Webcast and Replay - Stock Titan

Nov 11 Fireside Chat: Johnson & Johnson at UBS Global Healthcare Conference — Webcast and Replay Stock Titan

Johnson & Johnson Participates in the Inauguration of World Health Organization (WHO) Academy to Improve Training and Education of Health Workers Globally - Johnson & Johnson

Johnson & Johnson Participates in the Inauguration of World Health Organization (WHO) Academy to Improve Training and Education of Health Workers Globally Johnson & Johnson

Melanie & Susanne’s Story | J&J Switzerland - Johnson & Johnson

Melanie & Susanne’s Story | J&J Switzerland Johnson & Johnson

Development of a Convergent and Scalable Synthetic Route to Long-Acting RSV Inhibitor JNJ-7950 - ACS Publications

Development of a Convergent and Scalable Synthetic Route to Long-Acting RSV Inhibitor JNJ-7950 ACS Publications

How Johnson & Johnson is working to get medications to people around the world who need them most - Johnson & Johnson

How Johnson & Johnson is working to get medications to people around the world who need them most Johnson & Johnson

Hip replacement surgery - Johnson & Johnson

Hip replacement surgery Johnson & Johnson

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years - Business Wire

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years Business Wire

Value based healthcare - Johnson & Johnson

Value based healthcare Johnson & Johnson

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results - Business Wire

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results Business Wire

J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised - ts2.tech

J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised ts2.tech

Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook - Business Wire

Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook Business Wire

Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition - Yahoo Finance

Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition Yahoo Finance

Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire

Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference Business Wire

Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8% - Business Wire

Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8% Business Wire

Johnson & Johnson expands efforts to champion the nursing workforce globally - Business Wire

Johnson & Johnson expands efforts to champion the nursing workforce globally Business Wire

Our Credo - Johnson & Johnson

Our Credo Johnson & Johnson

Reconnecting the meaning of these two simple words: Health&Care - Johnson & Johnson

Reconnecting the meaning of these two simple words: Health&Care Johnson & Johnson

Meet 3 leaders who are breaking new ground for women in healthcare - Johnson & Johnson

Meet 3 leaders who are breaking new ground for women in healthcare Johnson & Johnson

6 ways Johnson & Johnson is using AI to help advance healthcare - Johnson & Johnson

6 ways Johnson & Johnson is using AI to help advance healthcare Johnson & Johnson

Global health equity - Johnson & Johnson

Global health equity Johnson & Johnson

What you need to know about Johnson & Johnson’s 2024 third quarter earnings - Johnson & Johnson

What you need to know about Johnson & Johnson’s 2024 third quarter earnings Johnson & Johnson

Environmental sustainability - Johnson & Johnson

Environmental sustainability Johnson & Johnson

4 questions for a data science innovator - Johnson & Johnson

4 questions for a data science innovator Johnson & Johnson

Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company - Johnson & Johnson

Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company Johnson & Johnson

Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations - Business Wire

Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations Business Wire

Innovation at J&J - Johnson & Johnson

Innovation at J&J Johnson & Johnson

Office of the Chief Medical Officer - Johnson & Johnson

Office of the Chief Medical Officer Johnson & Johnson

Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity - Johnson & Johnson

Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity Johnson & Johnson

What you need to know about Johnson & Johnson’s 2023 transparency report - Johnson & Johnson

What you need to know about Johnson & Johnson’s 2023 transparency report Johnson & Johnson

Uniting science and technology - Johnson & Johnson

Uniting science and technology Johnson & Johnson

ESG resources - Johnson & Johnson

ESG resources Johnson & Johnson

Working with the Senate HELP Committee - Johnson & Johnson

Working with the Senate HELP Committee Johnson & Johnson

Johnson & Johnson named to Fortune's 2024 America's Most Innovative Companies list - Johnson & Johnson

Johnson & Johnson named to Fortune's 2024 America's Most Innovative Companies list Johnson & Johnson

Suppliers - Johnson & Johnson

Suppliers Johnson & Johnson

Are super-personalized solutions the future of healthcare? - Johnson & Johnson

Are super-personalized solutions the future of healthcare? Johnson & Johnson

Johnson & Johnson Announces Collaborative Effort with USAID to Strengthen the Health Workforce Across Latin America and the Caribbean - Johnson & Johnson

Johnson & Johnson Announces Collaborative Effort with USAID to Strengthen the Health Workforce Across Latin America and the Caribbean Johnson & Johnson

Our company - Johnson & Johnson

Our company Johnson & Johnson

Vulnerability Reporting Program - Johnson & Johnson

Vulnerability Reporting Program Johnson & Johnson

How Johnson & Johnson's innovative supply chain technology is helping transform how we work—and live - Johnson & Johnson

How Johnson & Johnson's innovative supply chain technology is helping transform how we work—and live Johnson & Johnson

Veterans, military and military families - Johnson & Johnson

Veterans, military and military families Johnson & Johnson

Johnson & Johnson makes Fortune's 2018 Change the World list - Johnson & Johnson

Johnson & Johnson makes Fortune's 2018 Change the World list Johnson & Johnson

Improving access to medicine around the world - Johnson & Johnson

Improving access to medicine around the world Johnson & Johnson

Johnson & Johnson named a 2024 Fortune World’s Most Admired Company - Johnson & Johnson

Johnson & Johnson named a 2024 Fortune World’s Most Admired Company Johnson & Johnson

Latest news - Johnson & Johnson

Latest news Johnson & Johnson

Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat - Johnson & Johnson

Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat Johnson & Johnson

Johnson & Johnson has inaugurated the Innovation Hub at Campus Basel - Johnson & Johnson

Johnson & Johnson has inaugurated the Innovation Hub at Campus Basel Johnson & Johnson

Inclusion in Action: Special Olympics National Winter Games 2024 Sparks Inspiration - Johnson & Johnson

Inclusion in Action: Special Olympics National Winter Games 2024 Sparks Inspiration Johnson & Johnson

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting - PR Newswire

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting PR Newswire

Meet the determined woman who invented duct tape - Johnson & Johnson

Meet the determined woman who invented duct tape Johnson & Johnson

The importance of equality for Johnson & Johnson - Johnson & Johnson

The importance of equality for Johnson & Johnson Johnson & Johnson

9 Johnson & Johnson innovations that helped drive medicine forward - Johnson & Johnson

9 Johnson & Johnson innovations that helped drive medicine forward Johnson & Johnson

Johnson & Johnson Reaches 50 Million Children Through Sight For Kids Program - Johnson & Johnson

Johnson & Johnson Reaches 50 Million Children Through Sight For Kids Program Johnson & Johnson

4 ways Johnson & Johnson has worked to make access to medicines around the world more equitable - Johnson & Johnson

4 ways Johnson & Johnson has worked to make access to medicines around the world more equitable Johnson & Johnson

This healthcare company is determined to have the healthiest employees in the world - Johnson & Johnson

This healthcare company is determined to have the healthiest employees in the world Johnson & Johnson

D Scholars Award Program - Johnson & Johnson

D Scholars Award Program Johnson & Johnson

Top Johnson & Johnson Innovative Medicine Uk Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant